Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
165.40 USD | +0.30% |
|
+3.04% | +39.85% |
Jun. 18 | Deutsche Bank Adjusts Cardinal Health Price Target to $163 From $148 | MT |
Jun. 18 | Deutsche Bank Raises Price Target on Cardinal Health to $163 From $148, Keeps Hold Rating | MT |
Capitalization | 39.48B 34.42B 32.34B 29.41B 54.23B 3,429B 61.17B 382B 147B 1,562B 148B 145B 5,754B | P/E ratio 2025 * |
23.4x | P/E ratio 2026 * | 21.1x |
---|---|---|---|---|---|
Enterprise value | 42.33B 36.91B 34.67B 31.53B 58.14B 3,676B 65.58B 409B 158B 1,675B 159B 155B 6,169B | EV / Sales 2025 * |
0.19x | EV / Sales 2026 * | 0.16x |
Free-Float |
89.22% | Yield 2025 * |
1.24% | Yield 2026 * | 1.27% |
More valuation ratios
* Estimated data
More news
Last Transcript: Cardinal Health, Inc.
More recommendations
More press releases
More news
1 day | +0.30% | ||
1 week | +3.04% | ||
Current month | +7.10% | ||
1 month | +7.50% | ||
3 months | +25.19% | ||
6 months | +41.37% | ||
Current year | +39.85% |
1 week | 160.66 | ![]() | 166.02 |
1 month | 150.76 | ![]() | 166.02 |
Current year | 117.53 | ![]() | 166.02 |
1 year | 93.17 | ![]() | 166.02 |
3 years | 50.66 | ![]() | 166.02 |
5 years | 44.65 | ![]() | 166.02 |
10 years | 39.05 | ![]() | 166.02 |
Manager | Title | Age | Since |
---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 52 | 2022-08-31 |
Aaron Alt
DFI | Director of Finance/CFO | 54 | 2023-02-09 |
Michelle Greene
CTO | Chief Tech/Sci/R&D Officer | 55 | 2022-07-31 |
Director | Title | Age | Since |
---|---|---|---|
Gregory Kenny
CHM | Chairman | 72 | 2018-10-31 |
Director/Board Member | 72 | 2013-09-11 | |
Nancy Killefer
BRD | Director/Board Member | 70 | 2015-09-13 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.30% | +3.04% | +58.90% | +226.23% | 39.48B | ||
+0.63% | -0.26% | +20.89% | +142.51% | 91.2B | ||
-2.18% | -3.38% | - | - | 23.91B | ||
-0.15% | -8.63% | +37.68% | -2.44% | 10.03B | ||
-0.45% | -5.50% | -9.08% | -3.79% | 8.13B | ||
+0.44% | -4.27% | -17.02% | -1.29% | 7.27B | ||
+1.23% | -5.51% | -3.94% | +5.80% | 5.37B | ||
+0.35% | +0.87% | +16.66% | +33.49% | 5.24B | ||
+0.41% | +0.95% | +15.27% | -5.08% | 4.51B | ||
-1.17% | -7.34% | -1.56% | +14.58% | 3.5B | ||
Average | -0.05% | -2.14% | +13.09% | +45.56% | 19.86B | |
Weighted average by Cap. | +0.11% | +1.17% | +25.99% | +126.48% |
2025 * | 2026 * | |
---|---|---|
Net sales | 223B 195B 183B 166B 307B 19,396B 346B 2,158B 833B 8,836B 838B 820B 32,547B | 249B 217B 204B 185B 341B 21,593B 385B 2,403B 928B 9,837B 933B 913B 36,233B |
Net income | 1.7B 1.48B 1.39B 1.26B 2.33B 147B 2.63B 16.41B 6.34B 67.19B 6.37B 6.24B 247B | 1.78B 1.55B 1.46B 1.33B 2.45B 155B 2.76B 17.23B 6.65B 70.53B 6.69B 6.55B 260B |
Net Debt | 2.85B 2.48B 2.33B 2.12B 3.91B 247B 4.41B 27.53B 10.63B 113B 10.69B 10.46B 415B | 1.49B 1.3B 1.22B 1.11B 2.04B 129B 2.3B 14.36B 5.54B 58.8B 5.58B 5.46B 217B |
More financial data
* Estimated data
Employees
48,411
Sector
Pharmaceuticals
Calendar
Jun. 30
- Détachement de
Date | Price | Change | Volume |
---|---|---|---|
25-06-18 | 165.40 $ | +0.30% | 2,598,165 |
25-06-17 | 164.91 $ | +1.54% | 2,177,498 |
25-06-16 | 162.41 $ | +0.62% | 2,029,922 |
25-06-13 | 161.41 $ | +0.55% | 2,722,406 |
25-06-12 | 160.52 $ | +4.55% | 2,968,781 |
Delayed Quote Nyse, June 18, 2025 at 04:10 pm EDT
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
17
Last Close Price
165.40USD
Average target price
172.21USD
Spread / Average Target
+4.12%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CAH Stock
Select your edition
All financial news and data tailored to specific country editions